Thus far, abnormal endocannabinoid signalling, either due to their excessive production or to up-regulation of CB1R, which exerts damaging effects in diabetes, is considered a pathogenic factor in this inflammatory disease. This evidence concerns the gene CNR1 and diabetes mellitus.